Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Alarelin Delivery and Pikeperch Sperm Quality
2026-11-22
A controlled study in mature male pikeperch found that sustained-release alarelin treatment was associated mainly with later sperm-motility differences rather than greater sperm quantity. The findings support biological activity in a specific fish model and formulation, but do not establish improved fertilization, long-term reproductive performance, or general efficacy of the material outside that context.
EIPA and the Mechanics of Synchronous Release
2026-11-21
Jain et al. identified activity-dependent presynaptic filopodia as a structural element that can influence neurotransmitter release timing. Their convergent imaging, ultrastructural, perturbational and modeling evidence supports an NHE-associated membrane-flow mechanism, while the multifunctional pharmacology of EIPA limits target-specific interpretation.
EIPA and the Mechanics of Presynaptic Release
2026-11-20
Jain and colleagues link activity-dependent presynaptic filopodia to membrane remodeling, release-site clearance, and sustained synchronous neurotransmission. EIPA supports an association with sodium–hydrogen exchanger activity, but its broader ion-transport pharmacology means the study does not establish a target-exclusive mechanism.
EIPA and the Mechanics of Synchronous Release
2026-11-20
A 2026 study connects activity-dependent presynaptic filopodia with membrane flow, vesicle-clearance dynamics, and sustained synchronous neurotransmission. EIPA supports an NHE-associated mechanism, but its broader ion-transport pharmacology means the findings should be interpreted as pathway-level evidence rather than proof of a single molecular target.
EIPA and Presynaptic Membrane Mechanics
2026-11-19
Published evidence places EIPA within a convergent pharmacological and genetic test of activity-dependent presynaptic filopodia. The findings support an NHE-linked contribution to membrane remodeling and synchronous neurotransmitter release, but they do not establish EIPA as a TRPP3-specific probe in this neuronal context.
EIPA and Presynaptic Membrane Remodeling
2026-11-19
EIPA helps expose a link between sodium–hydrogen exchange, activity-dependent presynaptic filopodia, membrane flow, and synchronous neurotransmitter release—but its multitarget pharmacology limits target-specific conclusions.
How Fmoc-Phe-OH Functions in Fmoc Chemistry
2026-11-18
Fmoc-Phe-OH is a protected phenylalanine building block whose structure explains its conceptual role in amino acid protection and solid-phase peptide synthesis. Its documented identity, solvent behavior, and analytical characterization support structural interpretation, but they do not independently establish coupling efficiency or final peptide quality.
What Can AK-7 Reveal About SIRT2 in the CNS?
2026-11-18
AK-7 is documented as a selective, brain-permeable SIRT2 inhibitor. Its clearest research meaning is a target-level perturbation for asking how NAD+-dependent deacetylase activity relates to molecular and cellular readouts, not proof of disease modification or clinical benefit.
What Claustrum Markers Show Across Mammals
2026-11-17
A comparative study supports conserved molecular and topological organization across mammalian claustrum subdivisions, while showing that size, shape, cellular patterns, and marker interpretation remain species-dependent. The evidence is strongest for an anatomical framework, not for equivalent function or direct translation to humans.
Laurdan and Dynamic Lipid Nanoparticle Interfaces
2026-11-17
The cited study presents PEG-shedding kinetics as a way to balance nanoparticle stability with later cellular interaction. Laurdan is relevant as a membrane hydration and lipid-packing reporter, but its generalized polarization signal is an upstream biophysical measurement rather than a direct readout of PEG cleavage, mRNA delivery, or therapeutic efficacy.
How HDAC2 Selectivity Relates to Memory Readouts
2026-11-16
BRD6688 is documented as an HDAC inhibitor with reported kinetic selectivity for HDAC2 and effects on histone acetylation in neuronal systems. The key interpretive question is how an enzyme-level interaction relates to brain pharmacodynamic markers and memory-associated behavior, and where the evidence stops short of demonstrating a direct causal pathway.
How JNK-IN-7 Links Binding to Cell Signals
2026-11-16
JNK-IN-7 is described as a selective JNK inhibitor whose covalent interaction with JNK2 helps explain reported effects on c-Jun phosphorylation. Its biochemical potency, pathway-level readouts, and context-dependent effects on innate immune signaling represent different layers of evidence and should not be treated as interchangeable.
How to Interpret Anti-CD30 ADC Readouts
2026-11-15
Anti-CD30 Antibody (Brentuximab) links CD30 recognition to intracellular delivery of an anti-tubulin payload. Interpreting its evidence requires separating binding, internalization, payload action, and whole-system response.
How a β5 Proteasome Substrate Reports Activity
2026-11-14
Ac-WLA-AMC is documented as a fluorescent substrate for the β5 subunit of the 20S proteasome. Its scientific value lies in linking recognition and cleavage by a proteolytic active site to a fluorescence-based measurement, while the available documentation does not establish product-specific performance, selectivity across assay contexts, or quantitative results.
How 1,10-Phenanthroline Frames Cardiac Injury
2026-11-13
o-Phenanthroline, also known as 1,10-phenanthroline, provides a useful mechanistic lens for interpreting ischemia–reperfusion injury research. Its broad metal-chelating and MMP-inhibitory activity connects reduced lamin A proteolysis with improved functional readouts in an isolated rat-heart model, while leaving MMP-2 selectivity and clinical relevance unresolved.